GSTM1 and anemia: Therefore, in view of the detrimental effects of prolonged transfusion dependence, we investigated the rationale for early intervention with lenalidomide in TI patients with anemia (defined as Hb <10 g/dL) and low or Int‐1 IPSS risk del(5q) MDS.